Compositions for regenerating defective or absent myocardium
First Claim
Patent Images
1. An injectable graft composition for myocardial tissue regeneration, said composition comprising acellular extracellular matrix (ECM) from a mammalian tissue source comprising small intestine submucosa, said ECM comprising native matrix metalloproteases (MMPs), transforming growth factor-beta (TGF-β
- ), fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF), said ECM further comprising an exogenously added supplemental bioactive component comprising a collagen Type I protein, said supplemental collagen Type I protein comprising at least 0.1% by weight of said composition,said supplemental collagen Type I protein being linked to said ECM, wherein said supplemental collagen Type I protein interacts with said MMPs to modulate activity thereof and said VEGF to control and enhance angiogenesis and, thereby, matrix formation and remodeling when said composition is administered to damaged cardiovascular tissue.
4 Assignments
0 Petitions
Accused Products
Abstract
Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.
2 Citations
1 Claim
-
1. An injectable graft composition for myocardial tissue regeneration, said composition comprising acellular extracellular matrix (ECM) from a mammalian tissue source comprising small intestine submucosa, said ECM comprising native matrix metalloproteases (MMPs), transforming growth factor-beta (TGF-β
- ), fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF), said ECM further comprising an exogenously added supplemental bioactive component comprising a collagen Type I protein, said supplemental collagen Type I protein comprising at least 0.1% by weight of said composition,
said supplemental collagen Type I protein being linked to said ECM, wherein said supplemental collagen Type I protein interacts with said MMPs to modulate activity thereof and said VEGF to control and enhance angiogenesis and, thereby, matrix formation and remodeling when said composition is administered to damaged cardiovascular tissue.
- ), fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF), said ECM further comprising an exogenously added supplemental bioactive component comprising a collagen Type I protein, said supplemental collagen Type I protein comprising at least 0.1% by weight of said composition,
Specification